Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 ...

Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

SS-OCT has already been applied in the diagnosis and staging of conditions such as retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and glaucoma, and it is expected ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

EYE-103 is under clinical development by Eyebiotech and currently in Phase III for Diabetic Macular Edema. According to GlobalData, Phase III drugs for Diabetic Macular Edema have a 62% phase ...

Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...

Lt. Gen. Herzi Halevi is the most senior Israeli figure to resign over the security and intelligence breakdown on Oct. 7, 2023, when thousands of Hamas-led militants carried out a land ...

Israel's Top General Resigns Over Oct. 7 Failures, Adding to Pressure on Netanyahu JERUSALEM (AP) — Israel's top general resigned Tuesday, taking responsibility for security failures tied to ...